Navigation Links
New GranuFlo Lawsuit Website from Bernstein Liebhard LLP Provides Vital Dialysis Recall Information, Instructions on Filing a Claim
Date:10/27/2013

New York, NY (PRWEB) October 27, 2013

For individuals who may have experienced a stroke, heart attack, sudden cardiac death or another cardiovascular injury stemming from the now-recalled dialysis medication, a new GranuFlo lawsuit (http://www.granuflolawsuitclaims.com/) website from the attorneys at Bernstein Liebhard LLP is now available to answer any questions you have about filing a claim.

A growing number of dialysis patients have already filed lawsuits over the medication recalled in June 2012 alongside NaturaLyte, a fellow acid concentrate manufactured by Fresenius Medical Care. On its new website, the nationwide law firm will provide information about the side effects that have allegedly been associated with these dialysis drugs, which may include the risk for heart attacks, strokes, cardiopulmonary arrest, sudden cardiac death and other complications that may lead to dialysis death. NaturaLyte and GranuFlo side effects are allegedly experienced within 72 hours of receiving the drugs.

“As our Firm’s attorneys continue to hear from individuals who allegedly suffered the horrifying side effects of GranuFlo and NaturaLyte, our new website will prove vital to anyone seeking to file a claim against their manufacturer,” says Bernstein Liebhard LLP, a law firm representing victims of defective medical devices and drugs including GranuFlo and NaturaLyte. Potential GranuFlo lawsuit claimants may also call the firm directly to receive free and confidential case evaluations.

GranuFlo Lawsuits

According to an update issued October 17th by the U.S. Judicial Panel on Multidistrict Litigation (JPML), a total of 612 lawsuits have now been filed in a federal NaturaLyte and GranuFlo litigation underway in the U.S. District Court, District of Massachusetts.* These cases similarly allege that Fresenius Medical Care, a leading supplier of dialysis products and services in the U.S., failed to adequately warn about the life-threatening cardiovascular side effects associated with its products prior to issuing an Urgent Product Notification on March 29, 2012.

Following this public health announcement, the U.S. Food and Drug Administration (FDA) issued a Class I recall of Granuflo and NaturaLyte in June 2012 after learning of the drugs’ potential to cause fatal heart injuries in dialysis patients. A New York Times report published that month indicated that the federal agency became aware of an internal memo sent by Fresenius in November 2011 that contained information about 900 dialysis deaths that occurred after GranuFlo and NaturaLyte dialysis treatments.**The notice was only sent to physicians operating in clinics owned and operated by Fresenius.

According to the Times, the FDA had launched an investigation into whether Fresenius violated federal law in its handling of the GranuFlo recall. According to the article, doctors outside the company’s network did not know GranuFlo and NaturaLyte contained more of an ingredient the body converts to bicarbonate than similar medications, and that the difference could mean a patient’s experiencing elevated bicarbonate levels in the bloodstream. In turn, this may result in metabolic alkalosis, a condition that can allegedly lead to fatal or near-fatal cardiovascular injuries.

In addition to lawsuits filed at the federal court level, court documents indicate that numerous GranuFlo-related claims are also currently pending in a state court proceeding underway in Middlesex County Superior Court in Massachusetts. (In re Consolidated Fresenius Cases, No. MICV2013-03400-O)

Dialysis patients and their families may be entitled to compensation for injuries allegedly sustained within 72 hours of a dialysis treatment that used GranuFlo or NaturaLyte. Learn more about last year’s recall when you contact a GranuFlo lawyer or by visiting Bernstein Liebhard LLP’s website. For additional information, and to arrange for a free case review, please call 800-511-5092.

*jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-October-17-2013.pdf; U.S. Judicial Panel on Multidistrict Litigation, October 17, 2013
**nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html; New York Times, June 14, 2012

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.granuflolawsuitclaims.com/

Read the full story at http://www.prweb.com/releases/granuflo-lawsuit/granuflo-recall/prweb11271730.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Baron and Budd GranuFlo Lawsuit Lawyers Reviewing Claims Made By Dialysis Patients Allegedly Injured by GranuFlo
2. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal GranuFlo Recall Litigation
3. GranuFlo Lawsuits Mount, as Bernstein Liebhard LLP Notes New Consolidated Litigation for GranuFlo Recall Claims Filed in Massachusetts State Court
4. GranuFlo Lawsuit News: Bernstein Liebhard LLP Comments on Fresenius FDA Warning Letter, as GranuFlo Recall Claims Mount
5. GranuFlo Lawsuits News: Calif. Lawsuit Alleges Drug Maker Hid Serious Health Risks, Rottenstein Law Group LLP Reports
6. 201 Actions Pending in the Granuflo Multidistrict Litigation: Now, AttorneyOne Can Provide Advice
7. GranuFlo Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal GranuFlo Recall Litigation
8. NaturaLyte and GranuFlo Lawsuits Are Heating Up
9. New Fresenius NaturaLyte, GranuFlo Dialysis Heart Attack Lawsuit Allegations Update: Resource4thePeople Reports Important Hearing Is Scheduled in Fresenius Multidistrict Litigation
10. Rottenstein Law Group LLP Announces Launch of GranuFlo Lawsuit Center
11. GranuFlo Recall Lawyers at Wright & Schulte LLC Investigating GranuFlo Lawsuits on Behalf of Dialysis Patients Allegedly Injured by GanuFlo or NaturaLyte
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... IsoComforter, ... the introduction of the innovative newly improved Iso-Hip Wrap. The newly designed ... plush design enhances comfort and enables the patient to enjoy the benefits of ...
(Date:5/4/2016)... MD (PRWEB) , ... May 04, 2016 , ... ... Ostomy and Continence Nurses (WOCN) Society™ and Canadian Association for Enterostomal Therapy ... event promotion, time saving and planning tools to attendees and exhibitors for the ...
(Date:5/4/2016)... ... 04, 2016 , ... Washington Wellness Center today announced its tenth anniversary of ... What started out as an idea to provide a holistic approach to wellness has ... Developed by Dr. David Swanekamp, Chiropractic Physician , the wellness center offers a ...
(Date:5/4/2016)... ... May 04, 2016 , ... Momsense, Inc. ... The company’s patented technology, The Smart Breastfeeding Meter, is designed to monitor and ... technology is now available for purchase at Target.com . , Breastfeeding ...
(Date:5/4/2016)... ... May 04, 2016 , ... Natalie Jill is ... company MitoXcell in preparation of the launch of her new book: Natalie Jill’s 7 ... a nutritional guide designed to jump start a new healthy lifestyle featuring simple recipes ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... May 4, 2016 According to market ... and Demand Forecast to 2022 - Industry Insights by Slice ... Center and Others)" by P&S Market Research, the global ... 2015, and it is expected to grow at a CAGR ... slice type segment is expected to witness the faster growth, ...
(Date:5/4/2016)... Research and Markets has ... Myeloma Market and Competitive Landscape Highlights - ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ... Highlights 2016, provides comprehensive insights into Multiple ... Myeloma market valuations and forecast, Multiple Myeloma ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Acute lymphocytic ... 2016"  report to their offering.  ... Global Acute Lymphocytic Leukemia Market and ... into Acute Lymphocytic Leukemia pipeline products, Acute ...
Breaking Medicine Technology: